These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 26239517)
1. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6. Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517 [TBL] [Abstract][Full Text] [Related]
2. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma. Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156 [TBL] [Abstract][Full Text] [Related]
3. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling. Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566 [TBL] [Abstract][Full Text] [Related]
4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
5. MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. Dong S; Jin M; Li Y; Ren P; Liu J Oncol Rep; 2016 Apr; 35(4):2151-8. PubMed ID: 26847706 [TBL] [Abstract][Full Text] [Related]
6. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3. Li R; Liu J; Li Q; Chen G; Yu X Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618 [TBL] [Abstract][Full Text] [Related]
7. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
8. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151 [TBL] [Abstract][Full Text] [Related]
9. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway. Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841 [TBL] [Abstract][Full Text] [Related]
11. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. Wang X; Lu X; Geng Z; Yang G; Shi Y J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866 [TBL] [Abstract][Full Text] [Related]
12. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050 [TBL] [Abstract][Full Text] [Related]
13. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling. Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2. Qiu W; Yang Z; Fan Y; Zheng Q Oncotarget; 2016 Jun; 7(26):39907-39915. PubMed ID: 27223438 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541 [TBL] [Abstract][Full Text] [Related]
16. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
17. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060 [TBL] [Abstract][Full Text] [Related]
18. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Cao XZ; Bin H; Zang ZN Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451 [TBL] [Abstract][Full Text] [Related]
19. Circ_0011373 promotes papillary thyroid carcinoma progression by regulating miR-1271/LRP6 axis. Huang G; Mao L; Hu X Hormones (Athens); 2023 Sep; 22(3):375-387. PubMed ID: 37378808 [TBL] [Abstract][Full Text] [Related]
20. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]